Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 6, 2005, Pages 591-597

  Casanova, Ciro ^a   Cote, Claudia ^b   De Torres, Juan P ^b   Aguirre Jaime, Armando ^b   Marin, Jose M ^b   Pinto Plata, Victor ^b   Celli, Bartolome R ^b  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b NONE

Author keywords

Chronic obstructive pulmonary disease; Inspiratory capacity; Outcomes

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DYSPNEA; EPIDEMIOLOGICAL DATA; EXERCISE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LOGISTIC REGRESSION ANALYSIS; LUNG FUNCTION; LUNG INFLATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SEX RATIO; SURVIVAL RATE; TOTAL LUNG CAPACITY;

AGED; BODY MASS INDEX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSPIRATORY CAPACITY; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS; TIME FACTORS; TOTAL LUNG CAPACITY;

EID: 14944348630     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200407-867OC     Document Type: Article

References (36)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-1276.
2. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J, on behalf of the Task Force. Optimal assessement and management of chronic obstructive pulmonary disease. Eur Respir J 1995;8:1398-1420.
3. Celli BR, Snider GL, Heffner J. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-S120.
4. Pawels R, Buist SA, Calverley P, Jenkins C, Hurd S. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) - workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
5. Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, Lisboa C. Role of inspiratory capacity on exercise tolerance in COPD patients with and without expiratory flow limitation at rest. Eur Respir J 2000;16:269-275.
6. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:770-777.
7. Celli BR. Monitoring the progression of chronic obstructive pulmonary disease: time for new staging system. Eur Respir Rev 1999;9:165-168.
8. Celli BR. The importance of spirometry in COPD and asthma: effect on approach to management. Chest 2000;117:S15-S19.
9. Gerardi DA, Lovett L, Bennoti-Connors ML, Reardon JZ, Zu Wallack R. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J 1996;9:431-435.
10. Pinto-Plata VM, Cote C, Cabrai H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004;23:28-33.
11. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factor related to mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:544-549.
12. Schols AMWJ, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-1797.
13. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-1861.
14. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-1440.
15. Celli BR, Cote C, Marin JM, Casanova C, Montes de Oca M, Mendez R, Pinto-Plata V, Cabrai H. The Body Mass Index, Airflow Obstruction, Dyspnea, Exercise Performance (BODE) Index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012.
16. Wegner RE, Jörres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994;7:725-729.
17. Casanova C, Cole C, De Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Lung hyperinflation (IC/TLC) as a predictors of outcome in COPD patients [abstract]. Am J Respir Crit Care Med 2004;169:A588.
18. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies: American Thoracic Society Statement. Am Rev Respir Dis 1991;144:1202-1218.
19. O'Donnell DE, Web KA. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 1993;148:1351-1357.
20. American Thoracic Society. Guidelines for the Six-Minute Walk Test: American Thoracic Society Statement. Am J Respir Crit Care Med 2002;166:111-117.
21. Mahler D, Weels C. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-586.
22. Charlson M, Szatrowsky T, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251.
23. Hilgers RA. Distribution-free confidence bounds of ROC curves. Methods Inf Med 1991;30:96-101.
24. Vasan R, Larson M, Benjamin E, Evans J, Reiss C, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-1955.
25. Tantucci C, Duguet A, Similowsky T, Zelter M, Derenne JP, Milic-Emili J. Effect of salbutamol in dynamic hyperinflation in chronic obstructive pulmonary disease. Eur Respir J 1998;12:799-804.
26. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1395-1399.
27. O'Donnell DE, D'Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:663-668.
28. Di Marco F, Milic-Emili J, Boveri B, Carlucci P, Santus P, Casanova F, Cazzola M, Centanni S. Effect on inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J 2003;21: 86-94.
29. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003;124:1743-1748.
30. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-years follow-up study. Am Rev Respir Dis 1979;119:895-902.
31. Anthonisen NR, Wright EC, Hodking JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20.
32. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades RM, Monsó E, Serra-Batlles J, Antó JM. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:680-685.
33. De Godoy I, Donahoe M, Calhoun W, Mancino J, Rogers R. Elevated TNF-α production by peripheral blood monocytes of weigh-loosing COPD patients. Am J Respir Crit Care Med 1996;153:633-637.
34. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-813.
35. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE, National Emphysema Treatment Trial Research Group. A randomised trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
36. Martinez F, De Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung volume reduction improve dyspnoea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997;155:1984-1990.